Health: Make precision medicine work for cancer care

Nature

Volumn 520, Issue 7547, 2015, Pages 290-291

  Rubin, Mark A ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRASTUZUMAB; N-(4-(3-CHLORO-4-(2-PYRIDINYLMETHOXY)ANILINO)-3-CYANO-7-ETHOXY-6-QUINOLYL)-4-(DIMETHYLAMINO)-2-BUTENAMIDE; QUINOLINE DERIVATIVE;

ACCURACY; AGED; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER THERAPY; CASE REPORT; ECONOMIC ASPECT; FEMALE; FUNCTIONAL GENOMICS; GENE MUTATION; GENE SEQUENCE; HEALTH CARE COST; HUMAN; MOLECULARLY TARGETED THERAPY; NOTE; PRIORITY JOURNAL; TREATMENT FAILURE; URINARY TRACT CARCINOMA; ELECTRONIC MEDICAL RECORD; FACTUAL DATABASE; GENETICS; GENOMICS; HUMAN GENOME; INFORMATION DISSEMINATION; MEDICAL GENETICS; NEOPLASMS; PERSONALIZED MEDICINE; PHARMACOGENETICS; PROCEDURES; TIME; TRENDS; UTILIZATION;

DATABASES, FACTUAL; ELECTRONIC HEALTH RECORDS; FEMALE; GENETICS, MEDICAL; GENOME, HUMAN; GENOMICS; HUMANS; INDIVIDUALIZED MEDICINE; INFORMATION DISSEMINATION; MOLECULAR TARGETED THERAPY; NEOPLASMS; PHARMACOGENETICS; QUINOLINES; TIME FACTORS;

EID: 84928396805     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/520290a     Document Type: Note

References (10)

1. King, C. R., Kraus, M. H. & Aaronson, S. A. Science 229, 974-976 (1985).
2. Hudziak, R. M., Schlessinger, J. & Ullrich, A. Proc. Natl Acad. Sci. USA 84, 7159-7163 (1987).
3. Rabindran, S. K. et al. Cancer Res. 64, 3958-3965 (2004).
4. Kaushal, R. et al. J. Am. Med. Informat. Assoc. 21, 587-590 (2014).
5. Flaherty, K. T. et al. N. Eng. J. Med. 363, 809-819 (2010).
6. Wang, F. et al. Science 340, 622-626 (2013).
7. Ramos, P. & Bentires-Alj, M. Oncogene http://dx.doi.org/10.1038/onc.2014.314 (2014).
8. Massard, C. Ann. Oncol. 26, (suppl. 2) ii4 (2015).
9. Slamon, D. J. et al. N. Eng. J. Med. 344, 783-792 (2001).
10. Slamon, D. et al. N. Eng. J. Med. 365, 1273-1283 (2011).